Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin versus placebo for Indigenous children with bronchiectasis
ACTRN12610000383066Phase 3Completed
- Sponsor
- Menzies School of Health Research
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis comparing Azithromycin once weekly with Placebo once weekly (2 arms). Primary endpoint: Rate of pulmonary exacerbations of bronchiectasis. Started Nov 2008; status: completed.
02
Drugs
azithromycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ACTRN12610000383066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000383066.